In the realm of global health, the battle against cervical cancer stands as a critical test of our collective commitment to equity and access. This article delves into a pivotal roundtable discussion held at the Africa Health Business Symposium 2026, where experts converged to address the urgent need for equitable HPV prevention and cervical cancer screening in Kenya. What makes this conversation particularly fascinating is its focus on translating policy into tangible, equitable impact at the population level.
Context: A Global Challenge with Local Impact
Cervical cancer, despite being largely preventable, continues to claim the lives of thousands of women annually, especially in low- and middle-income countries. Kenya, with its ambitious Cervical Cancer Elimination Action Plan, is at a crossroads. The disease remains the second most common cancer among women, with an estimated 5,845 new cases and 3,600 deaths each year. This stark reality underscores the urgency of the matter.
Critical Developments and Opportunities
Strong Policy Commitment
Kenya's alignment with the WHO's 90-70-90 targets is a significant step forward. However, as I see it, the true challenge lies in ensuring that this robust plan translates into effective county-level implementation and measurable outcomes.
Transforming HPV Vaccination
The shift to a single-dose HPV vaccination schedule is a game-changer. By simplifying logistics and reducing costs, this innovation has the potential to significantly expand coverage and reach previously underserved populations. It's an operational breakthrough with far-reaching implications.
Advancements in Screening
The introduction of HPV DNA testing and self-sampling methods offers a promising solution to long-standing barriers in facility-based screening. If successfully scaled, these approaches could revolutionize early detection, particularly for underserved communities.
Health Financing Reforms
Reforms under the Social Health Authority present an opportunity to integrate cervical cancer services into Kenya's Universal Health Coverage framework. This could provide financial protection and strategic purchasing of essential interventions, but as I perceive it, the devil is in the details. Prioritizing preventive services within benefit packages will be crucial to ensure effective implementation.
Global Momentum and Vaccine Innovation
Global efforts, led by organizations like Gavi, are supporting the development of higher-valency HPV vaccines, offering broader protection. This presents Kenya with an opportunity to future-proof its vaccination strategy and enhance its impact on cervical cancer incidence. However, the challenge lies in aligning these global advancements with local implementation.
Reframing Cervical Cancer
There's a growing recognition that cervical cancer is not just a health issue but a gender equity and socio-economic development challenge. It disproportionately affects women in low-income, rural settings, exacerbating existing inequalities. Addressing this disease requires a multi-sectoral approach and whole-of-society engagement.
Critical Gaps and Challenges
Low Screening Coverage
Screening remains a weak link in Kenya's cervical cancer control strategy. With uptake estimated at below 10%, most cases are diagnosed at advanced stages, limiting treatment options and increasing mortality. This not only impacts individual lives but also places a heavy burden on healthcare systems.
Limited Vaccination for Adult Women
While Kenya has made progress in vaccinating adolescent girls, adult women, who are also at risk, are often excluded from national vaccination strategies. Emerging global guidance supports including adult cohorts, but clear policy direction and financing pathways are lacking.
Persistent Inequities
Significant disparities exist across counties and vulnerable populations. Rural, peri-urban, and marginalized communities face compounded barriers, leading to uneven coverage of vaccination and screening services. This reinforces geographic and socio-economic health disparities.
Fragmentation and Misalignment
Despite robust policy frameworks, there's a disconnect between national policies, county-level implementation, and financing mechanisms. This fragmentation limits the scalability of interventions and undermines the effectiveness of prevention strategies.
Weak Community-Financing Linkage
Community awareness efforts often create demand without corresponding service availability or financial protection. This gap leads to unmet needs and reduced trust over time. Bridging this divide requires integrating community systems into national planning and budgeting processes.
Data and Evidence Gaps
Reliable, real-time data is limited, particularly at sub-national levels. The lack of integrated programmatic data and patient outcomes hampers responsive policy-making and efficient resource allocation. Strengthening data ecosystems is crucial for informed decision-making.
Strategic Imperative
The way forward for Kenya is clear: move beyond policy adoption to coordinated, equity-focused implementation. This means aligning community systems, service delivery, and financing mechanisms to ensure universal access to effective HPV prevention, screening, and care.
Focus of the Roundtable
This high-level roundtable aims to go beyond challenges and explore practical, scalable solutions. A key premise is the critical role of community systems and civil society in driving equity. The discussion will delve into strategies for building trust, addressing socio-cultural barriers, and institutionalizing community engagement within national health systems.
Scaling Community-Led Models
Kenya has successful community-driven models, but they need to be scaled and integrated into national programs. The session will focus on scaling HPV self-sampling and outreach screening models, leveraging digital health tools, and identifying operational enablers for institutionalization.
Public-Private Collaboration
Achieving national scale requires a coordinated, multi-sectoral approach. The roundtable will examine defined roles across public and private sectors, harnessing private sector capacity in diagnostics and service delivery. Models for innovation adoption and equity safeguards will be crucial to prevent widening access disparities.
Translating Demand into Policy and Financing
A persistent gap exists between community-level demand and national financing mechanisms. The session will explore how to bridge this divide by aligning community needs with policy priorities and budget allocations, integrating cervical cancer services into UHC frameworks, and strengthening strategic purchasing mechanisms.
Strengthening the Continuum of Care
Cervical cancer elimination requires an integrated, end-to-end continuum of care. The session will focus on strengthening linkages between vaccination, screening, diagnosis, and treatment, addressing bottlenecks in referral systems, and aligning financing mechanisms to support patient-centered care pathways.
Featured Contribution
Phoebe Ongadi, Executive Director of KENCO, will deliver scene-setting remarks, anchoring the discussion in community realities and lived experiences. Her perspective will ensure the conversation remains grounded in equity and real-world implementation, emphasizing the need to close the gap for adult women in HPV prevention and the central role of communities in driving demand and trust.
Looking Ahead
Kenya has made commendable progress, but the evidence is clear: cervical cancer elimination demands a sustained focus on equity, strengthened community systems, and aligned financing. The next phase must prioritize implementation precision, ensuring interventions are not just available but accessible and utilized by all populations. This roundtable aims to catalyze action, generating insights to inform national strategies and partnership models.
